Phase <scp>II</scp> Study of Nivolumab and Ipilimumab for Treatment of Metastatic/Recurrent Adenoid Cystic Carcinoma (<scp>ACC</scp>) of all Anatomic Sites of Origin and Other Malignant Salivary Gland Tumors

Authors

Sukjun Kim (ORCID: https://orcid.org/0000-0002-3190-9829)
Devalingam Mahalingam (ORCID: https://orcid.org/0000-0002-2979-9894)
Liam Il‐Young Chung (ORCID: https://orcid.org/0000-0001-6541-793X)
Victoria Villaflor (ORCID: https://orcid.org/0000-0002-9111-1034)
Borislav A. Alexiev (ORCID: https://orcid.org/0000-0002-0262-2263)
Sangwon Shin (ORCID: https://orcid.org/0009-0003-2626-3052)
Richard Duan (ORCID: https://orcid.org/0000-0003-4098-262X)
Irene Helenowski (ORCID: https://orcid.org/0000-0003-1606-9013)
Maria Matsangou
Young Kwang Chae (ORCID: https://orcid.org/0000-0003-1557-7235)
Youjin Oh (ORCID: https://orcid.org/0000-0002-9012-5258)

Institutions

Northwestern University (US)
City Of Hope National Medical Center (US)
Astellas Pharma (United States) (US)

Publication Details

Journal: Cancer Medicine
Published: 2025-04-01
DOI: https://doi.org/10.1002/cam4.70724
Citations: 4
Primary Topic: Salivary Gland Tumors Diagnosis and Treatment
Type: article
Field-Weighted Citation Impact: 8.03

Funders

Bristol-Myers Squibb Foundation
Bristol-Myers Squibb

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Phase II Study of Nivolumab and Ipilimumab for Treatment of Metastatic/Recurrent Adenoid Cystic Carcinoma (ACC) of all Anatomic Sites of Origin and Other Malignant Salivary Gland Tumors

Sukjun Kim, Devalingam Mahalingam, Liam Il‐Young Chung, Victoria Villaflor et al.

Apr 1, 2025

4 citations

Cancer Medicine

Salivary Gland Tumors Diagnosis and Treatment

8.03

article

Phase II Study of Nivolumab and Ipilimumab for Treatment of Metastatic/Recurrent Adenoid Cystic Carcinoma (ACC) of all Anatomic Sites of Origin and Other Malignant Salivary Gland Tumors

Sukjun Kim, Devalingam Mahalingam, Liam Il‐Young Chung, Victoria Villaflor, Borislav A. Alexiev, Sangwon Shin, Richard Duan, Irene Helenowski, Maria Matsangou, Young Kwang Chae, Youjin Oh

April 1, 2025article en

4 citations

Abstract

No abstract available for this paper.

Cancer MedicineVol. 14(7)

Northwestern University (US), City Of Hope National Medical Center (US), Astellas Pharma (United States) (US)

Bristol-Myers Squibb Foundation, Bristol-Myers Squibb

Good health and well-being

Openalex Percentile: Top 3%

Salivary Gland Tumors Diagnosis and Treatment

8.03

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.